Expand ASBP Menu
ASBP MENU

ASBP Latest Press Releases

-- June 26, 2026 --

Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing Globe Newswire 8:35 AM

-- June 24, 2026 --

Aspire Biopharma's BUZZ BOMB(TM) Launches on Amazon, Introducing Next-Generation Caffeine Stick Packs ACCESS Newswire 8:30 AM

-- June 23, 2026 --

Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th Globe Newswire 8:35 AM

-- June 17, 2026 --

Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th Globe Newswire 10:57 AM

-- June 12, 2026 --

Aspire Biopharma Announces Signing of Definitive Share Purchase Agreement to Acquire Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue ACCESS Newswire 8:30 AM

-- May 28, 2026 --

Aspire Biopharma Issues Shareholder Letter ACCESS Newswire 8:30 AM

-- May 27, 2026 --

Aspire Biopharma's BUZZ BOMBTM Partners with EoS Fitness to Empower High-Performance Lifestyles for Millions of Members ACCESS Newswire 8:30 AM

-- May 7, 2026 --

Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio ACCESS Newswire 11:00 AM

-- April 27, 2026 --

Aspire Biopharma Announces $5.0 Million Share Repurchase Program ACCESS Newswire 8:30 AM

-- April 20, 2026 --

Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Acquisition ACCESS Newswire 8:30 AM

-- April 17, 2026 --

Aspire Biopharma's Buzz Bomb(TM) Caffeine Company's Brand Ambassador, Ashley Paulson, to Attempt Fastest 100-Mile Treadmill Run at 2026 Boston Marathon Expo ACCESS Newswire 8:00 AM

-- April 16, 2026 --

Aspire Biopharma Has Entered Into a Letter of Intent to Acquire a Leading Global Automotive Supplier With a 100+ Year History and $200M+ in 2025 Revenue ACCESS Newswire 8:30 AM

-- April 15, 2026 --

Aspire Biopharma's Buzz Bomb Caffeine Company Partners with Interwest Brokerage to Accelerate Retail Expansion ACCESS Newswire 8:00 AM

-- March 19, 2026 --

Aspire Biopharma's Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion ACCESS Newswire 8:05 AM

-- March 17, 2026 --

Aspire Biopharma's Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director ACCESS Newswire 8:30 AM

-- March 12, 2026 --

Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026 ACCESS Newswire 8:00 AM

-- March 10, 2026 --

Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack ACCESS Newswire 8:30 AM

-- March 3, 2026 --

Aspire Biopharma Partners with Microsize to Develop Rapid-delivery Sublingual Powder Formulation of Alprazolam for Faster Anxiety Relief ACCESS Newswire 8:00 AM

-- February 25, 2026 --

Aspire Biopharma's Buzz Bomb(TM) Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon Sponsorship ACCESS Newswire 8:30 AM

-- February 20, 2026 --

Aspire Biopharma Regains Full Compliance with Nasdaq Listing Requirements ACCESS Newswire 8:00 AM

-- February 19, 2026 --

Aspire Biopharma's Buzz Bomb Caffeine Company Names ChicExecs as Public Relations Agency of Record ACCESS Newswire 8:00 AM
Market Data Delayed 15 Minutes